Literature DB >> 12829957

Does screening for loss of lung function help smokers give up?

Sally Wells1, Simon de Lusignan.   

Abstract

One-fifth of smokers show accelerated decline in lung function. These are the patients that go on to develop chronic obstructive pulmonary disease (COPD), an illness characterized by cough, production of sputum, shortness of breath and premature death (Sethi and Rochester, 2000). If this group of smokers stopped smoking, their decline would slow and they might avoid developing COPD. This pilot study aimed to discover whether those with accelerated decline in lung function would quit if presented with the facts about their situation. Known smokers in their 50s were screened for signs of accelerated respiratory decline. Those with an accelerated decline in lung function were identified and given tailored smoking cessation advice. Of 141 eligible patients, 22 responded and six gave up smoking and remained non-smokers 1 year later. The results of this pilot suggest that screening smokers for accelerated respiratory decline by practice nurses is feasible and acceptable to those patients that respond. Further research is needed to discover whether such an intervention would be cost-effective.

Entities:  

Mesh:

Year:  2003        PMID: 12829957     DOI: 10.12968/bjon.2003.12.12.11337

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  2 in total

1.  Why do smokers diagnosed with COPD not quit smoking? - a qualitative study.

Authors:  Britt-Marie Eklund; Siv Nilsson; Linnea Hedman; Inger Lindberg
Journal:  Tob Induc Dis       Date:  2012-10-22       Impact factor: 2.600

2.  Genetic test to stop smoking (GeTSS) trial protocol: randomised controlled trial of a genetic test (Respiragene) and Auckland formula to assess lung cancer risk.

Authors:  John A A Nichols; Paul Grob; Simon de Lusignan; Wendy Kite; Peter Williams
Journal:  BMC Pulm Med       Date:  2014-05-01       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.